Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28928818 | 0.88 | NPC1 (0.51) | KDM4ENPC1RAB9AGAASMN1; SMN2 | |
| SCHEMBL28929181 | 0.88 | AOC3 (0.43) | KDM4ENPC1RAB9AGAASMN1; SMN2 | |
| SCHEMBL28929413 | 0.85 | GAA (0.45) | KDM4EGAALMNA | |
| SCHEMBL28928831 | 0.83 | KDM4E (0.42) | KDM4EGAALMNAPOLB | |
| SCHEMBL28928845 | 0.83 | NPC1 (0.40) | KDM4ENPC1RAB9AGAALMNA | |
| SCHEMBL28928850 | 0.81 | PKM (0.44) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28929404 | 0.80 | NPC1 (0.62) | KDM4ENPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL28928872 | 0.79 | LMNA (0.62) | KDM4ENPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL28929179 | 0.79 | NPC1 (0.47) | KDM4ENPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL28928843 | 0.79 | POLB (0.50) | KDM4ENPC1RAB9AGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115583942-A | 2-substituted 5-phenyl-oxazole derivative, preparation method thereof and application thereof as MNK (MNK) inhibitor | 中国海洋大学 | 2023-01-10 | — | — | CN | disclosed |